Warning letter
Pensacola Apothecary, Inc. DBA Everwell Specialty Pharmacy: warning letter of Jun 28, 2017
FDA warning letter 524550 · Dallas District Office
Key facts
| Reference number | 524550 |
|---|---|
| Company | Pensacola Apothecary, Inc. DBA Everwell Specialty Pharmacy |
| Subject | New Drug/Misbranded |
| Issue date | Jun 28, 2017 |
| Posted date | Jul 25, 2017 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| CFR sections cited | 200.10(b), 211.67(a), 211.165(a), 210.1(b), 530 |
| Inspection city | Pensacola |
| Inspection ZIP | 32504 |
| Inspection start date | Aug 22, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: